New drug gemini tested for kidney disease safety
Disease control
Completed
This early-stage study tested a single dose of an experimental drug called Gemini in 40 adults with moderate to severe chronic kidney disease (stages 3 and 4). The main goal was to check if Gemini is safe and tolerable compared to a placebo. Researchers also measured how the drug…
Phase: PHASE1, PHASE2 • Sponsor: Revelation Biosciences, Inc • Aim: Disease control
Last updated Apr 24, 2026 16:05 UTC